Statistics

Total Visits

Views
Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP53

Select a period of time:

Number of views in the range

Views
Efficacy and Safety of Eltrombopag in Persistent and Newly Diagnosed ITP22

Views

Views
November 20250
December 20251
January 20260
February 20260
March 202615
April 20266
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
Germany2
Brazil2
Canada1
Chile1
Spain1
Finland1
Mexico1
El Salvador1
 

Top cities views

Views
San Jose11
Frankfurt am Main1
Fuentes de León1
Helsinki1
Itapecerica da Serra1
Leipzig1
Montreal1
San Luis Potosí City1
San Salvador1
Santiago1